Julio Delgado, MD, PhD

Consultant
Hospital Clínic Barcelona-IDIBAPS, Spain

N/A

Poster(s):

• 1101 - An immuno-(epi)genomic classification of chronic lymphocytic leukemia refines outcome prediction

• 1905 - Academic CD19-directed CAR-T ARI-0001 (varnimcabtagene autoleucel) for patients with relapsed/refractory chronic lymphocytic leukemia and Richter’s transformation